Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (2) Autor Almeida Jr,João Nóbrega de (2) Rossi,Flávia (2) Cury,Ana Paula (1) Dal-Paz,Karine (1) Di Gioia,Thais Sabato Romano (1) Duarte,Alberto José da Silva (1) Félix,Cássia da Silva (1) Girardello,Raquel (1) Lima,Ana Lucia Lei Munhoz (1) Oliveira,Priscila Rosalba Domingos de (1) Paula,Adriana Pereira de (1) Mais... Palavra-chave Bacterial ecology (1) Brazil (1) Carbapenems (1) Colistin-resistant (1) Drug resistance (1) Enterobacteriaceae (1) Polymyxin B-resistant (1) Mais... Tipo do documento Info:eu-repo/semantics/article (1) Info:eu-repo/semantics/other (1) Ano 2017 (1) 2011 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última Carbapenem stewardship: positive impact on hospital ecology BJID Lima,Ana Lucia Lei Munhoz; Oliveira,Priscila Rosalba Domingos de; Paula,Adriana Pereira de; Dal-Paz,Karine; Almeida Jr,João Nóbrega de; Félix,Cássia da Silva; Rossi,Flávia. INTRODUCTION: Excessive group 2 carbapenem use may result in decreased bacterial susceptibility. OBJECTIVE: We evaluated the impact of a carbapenem stewardship program, restricting imipenem and meropenem use. METHODS: Ertapenem was mandated for ESBL-producing Enterobacteriaceae infections in the absence of non-fermenting Gram-negative bacilli (GNB) from April 2006 to March 2008. Group 2 carbapenems were restricted for use against GNB infections susceptible only to carbapenems and suspected GNB infections in unstable patients. Cumulative susceptibility tests were done for nosocomial pathogens before and after restriction using Clinical and Laboratory Standards Institute (CLSI) guide-lines.Vitek System or conventional identification methods were performed... Tipo: Info:eu-repo/semantics/article Palavras-chave: Carbapenems; Drug resistance; Bacterial ecology. Ano: 2011 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702011000100001 Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years BJID Rossi,Flávia; Girardello,Raquel; Cury,Ana Paula; Di Gioia,Thais Sabato Romano; Almeida Jr,João Nóbrega de; Duarte,Alberto José da Silva. Abstract Colistin resistance involving Gram-negative bacilli infections is a challenge for health institutions around of the world. Carbapenem-resistance among these isolates makes colistin the last therapeutic option for this treatment. Colistin resistance among Enterobacteriaceae, Acinetobacter spp., and Pseudomonas spp. was evaluated between 2010 and 2014 years, at Hospital das Clínicas, São Paulo, Brazil. Over five years 1346 (4.0%) colistin resistant Gram-negative bacilli were evaluated. Enterobacteriaceae was the most frequent (86.1%) pathogen isolated, followed by Acinetobacter spp. (7.6%), and Pseudomonas spp. (6.3%). By temporal analysis there was a trend for an increase of colistin resistance among Enterobacteriaceae, but not among... Tipo: Info:eu-repo/semantics/other Palavras-chave: Colistin-resistant; Polymyxin B-resistant; Enterobacteriaceae; Brazil. Ano: 2017 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000100098 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco